Download PDF Flyer
Impact Factor Current: 2.719
5 - Year: 2.994

Current Vascular Pharmacology

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Volume 20 , Issue 6 , 2022

This journal supports open access

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.719
5 - Year: 2.994

Ranking & Category

  • 42nd of 65 in Peripheral Vascular Disease
  • 164th of 261 in Pharmacology & Pharmacy

Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Abstracted/Indexed in


BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Current Contents® - Clinical Medicine, Current Contents® - Life Sciences, Dimensions, EBSCO, EMBASE/Excerpta Medica, ERA 2018, Genamics JournalSeek, Google Scholar, InCites, Index Copernicus, J-Gate, Journal Citation Reports/Science Edition, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed/Index Medicus, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Science Citation Index Expanded™ (SciSearch®), Scilit, Scopus, Suweco CZ, TOC Premier and Ulrich's Periodicals Directory

Journal History

Current Vascular Pharmacology Journal was launched in 2003. Dr. Dimitri P. Mikhailidis serves as the Editor-in-Chief of the journal.

Endorsement(s)
"Essential reading for cardiovascular scientists and physicians, pharmaceutical organizations and medical universities."

Greg Dusting
Univ. of Melbourne, Australia
COPE COMPLIANT
Authors' Comments

I do want to compliment Bentham on the excellent processing of my manuscripts—the editorial and production works have been outstanding.


Thomas F. Whayne
(Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky Lexington, KY, United States.)

Has contributed: Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving.
© 2022 Bentham Science Publishers | Privacy Policy